ABYNTEK EXHIBITING AT THE EACR CONGRESS 2022
The annual EACR (European Association for Cancer Research) Congress brings together thousands of leading cancer researchers during four days to inspire innovation and build knowledge, connections and collaborations. Founded in 1968 and with more than 10,000 members...
Synthetic biomarkers for early cancer detection
The detection of endogenous cancer biomarkers (cell-free nucleic acids, proteins, lipids, metabolites) within blood and urine is a promising strategy for early cancer detection. At present, prostate-specific antigen (PSA) is the most widespread blood biomarker for...
Molecular targets in metastatic colorectal cancer
Colorectal cancer (CRC) is the third most common cancer worldwide and the second cause of cancer death. Chemotherapy and surgery have long been the first line therapies to treat this disease; however, curative treatments are not always achieved, as nearly a quarter of...
Tumor markers in cancer research: Questions and answers
This article is intended to answer some of the key questions regarding tumor markers for cancer research. First of all, we will explain what tumor markers are, what they are used for and their main characteristics. Then, we will focus on the main trends in oncological...
